Home

Bacil Pharma Ltd PE Ratio

Image

Bacil Pharma Ltd

NSE: BACILPHARMA

PE

74

Last updated on: Apr 11, 2025

Key Highlights

  • The P/E Ratio of Bacil Pharma Ltd is 74 as of 11 Apr 14:21 PM .
  • The P/E Ratio of Bacil Pharma Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Latest Trading Price of Bacil Pharma Ltd is ₹ 43.68 as of 04 Apr 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 159.2. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Bacil Pharma Ltd

No data available

Company Fundamentals for Bacil Pharma Ltd

Image

Bacil Pharma Ltd

NSE: BACILPHARMA

Share Price

₹ 43.68

-2.10 (-4.59%)

stock direction

Last updated on: Apr 04, 2025

Market Price of Bacil Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Bacil Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
04 Apr 202543.68
03 Apr 202545.78
02 Apr 202543.82
01 Apr 202544.5
28 Mar 202542.49
27 Mar 202541.9
26 Mar 202540.03
25 Mar 202541.31
24 Mar 202540
21 Mar 202540.56

SWOT Analysis Of Bacil Pharma Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Bacil Pharma Ltd

Asset Value vs Market Value of Bacil Pharma Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Bacil Pharma Ltd25.73
Sun Pharmaceutical Industries Ltd396394
Divis Laboratories Ltd142920
Cipla Ltd114383
Torrent Pharmaceuticals Ltd105812
Mankind Pharma Ltd95481

PE Ratio of Bacil Pharma Ltd Explained

25.73

Market cap

0

Earnings

74.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Bacil Pharma Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Bacil Pharma Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Bacil Pharma Ltd

No data available

* All values are in %

About Bacil Pharma Ltd

  • Incorporated as a private limited company in Maharashtra in May '87, Bacil Pharma (BPL) was converted into a public limited company in Oct.'90.
  • The main business activity of the Company is Pharmaceutical. Bal Pharma is a fully integrated and leading Indian pharmaceutical company specialized in Prescription drugs, Branded Formulations, APIs, Generic & OTC products, Intravenous Infusions and Bulk Drugs.
  • Domestic operations are spread across pan India.
  • The company has strong field force of 500 plus, spread over various States and Districts.
  • It has a strong distribution set up, with Super Stockist in all the States and stockists for retail coverage.

Bacil Pharma Ltd News Hub

Bacil Pharma reports standalone net loss of Rs 0.03 crore in the June 2024 quarter

Net loss of Bacil Pharma reported to Rs 0.03 crore in the quarter ended June 2024 as against net pro

Read more

14 Aug 24

Bacil Pharma to discuss results

Bacil Pharma will hold a meeting of the Board of Directors of the Company on 14 August 2024. Powered

Read more

10 Aug 24

Bacil Pharma schedules AGM

Bacil Pharma announced that the Annual General Meeting (AGM) of the company will be held on 27 Septe

Read more

11 Sept 24

Bacil Pharma to conduct AGM

Bacil Pharma announced that the Annual General Meeting (AGM) of the company will be held on 27 Septe

Read more

11 Sept 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Bacil Pharma Ltd

What is the current PE Ratio of Bacil Pharma Ltd?

The Current PE Ratio of Bacil Pharma Ltd is 74.03 as on 11 Apr 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 11 Apr 2025.

What was the PE Ratio of Bacil Pharma Ltd last year?

The PE Ratio of Bacil Pharma Ltd was 0.0 last year, now the PE ratio is 74.03, showing a year-on-year growth of -%.

What does the PE Ratio of Bacil Pharma Ltd indicate about its stock?

The PE Ratio of Bacil Pharma Ltd is 74.03. This ratio indicates that investors are willing to pay 74.03 times the earnings per share for each share of Bacil Pharma Ltd.

What is the PE Ratio Growth of Bacil Pharma Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Bacil Pharma Ltd grew by -% whereas, the EPS ratio grew by -112.2.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions